Market Overview

3 Most Likely Suitors For Colgate-Palmolive, In Jefferies' View

Share:
3 Most Likely Suitors For Colgate-Palmolive, In Jefferies' View
Related CL
Watch These 8 Huge Call Purchases In Thursday Trade
Benzinga's Option Alert Recap From September 13
Related CHD
22 Stocks Moving In Thursday's Pre-Market Session
Earnings Scheduled For August 3, 2017

Colgate-Palmolive Company (NYSE: CL) CEO Ian Cook recently made headlines by saying he would accept a hypothetical buyout offer for the company of $100 per share. While there are no confirmed reports of buyout discussions ongoing, the quote now has traders speculating about which companies could be interested in a Colgate-Palmolive takeover.

Open an Ally Invest account and trade for as low as $3.95 per transaction.

3 Strong Contenders

The New York Post mentioned Unilever plc (ADR) (NYSE: UL), Johnson & Johnson (NYSE: JNJ) and Berkshire Hathaway Inc. (NYSE: BRK-A) (NYSE: BRK-B)/3G as potential suitors. Of the three names mentioned, Johnson & Johnson is the most likely buyer, Jefferies analyst Kevin Grundy said.

“We believe JNJ is the most likely suitor, at this juncture, as we are not of the view that ULVR is likely to make an approach right away following its recent strategic announcements,” Grundy said.

Related Link: Wall Street's M&A Chatter From May 17: SiriusXM-Pandora, WebMD, Colgate, Calpine

Rumors that either Johnson & Johnson or Unilever could be interested in buying Colgate-Palmolive have been around since at least 2011.

Looking At The Numbers

A buyout of Colgate-Palmolive would result in 13–18 percent EPS accretion for Unilever and 6–8 percent EPS accretion for Johnson & Johnson, Grundy said.

Still, the buyout rumors aren’t enough to make Colgate-Palmolive a buy.

“While we are favorably predisposed to high margin, high return businesses with attractive growth profiles and M&A optionality, we remain on the sidelines given the deterioration in Colgate’s topline trends and the uncertain outlook in EMs,” Grundy said.

Instead, Church & Dwight Co., Inc (NYSE: CHD) is the best option for investors looking to play potential consolidation in the cosmetics, household and personal care market, Grundy said.

Jefferies maintains a Hold rating and $76 price target for Colgate-Palmolive.

______
Image Credit: By Internet Archive Book Images [No restrictions],via Wikimedia Commons

Latest Ratings for CL

DateFirmActionFromTo
Sep 2017MacquarieInitiates Coverage OnNeutral
Apr 2017JefferiesInitiates Coverage OnHold
Mar 2017JP MorganInitiates Coverage OnNeutral

View More Analyst Ratings for CL
View the Latest Analyst Ratings

Posted-In: Ian Cook JefferiesAnalyst Color News Rumors Reiteration M&A Analyst Ratings Best of Benzinga

 

Related Articles (BRK-A + BRK-B)

View Comments and Join the Discussion!
Loading...
Loading...